Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial - Engert, A; Haverkamp, H; Kobe, C (Lancet, 2012)
et al.